173 related articles for article (PubMed ID: 17850589)
41. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
Kim S; Shen T; Min B
J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
[TBL] [Abstract][Full Text] [Related]
42. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
43. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
44. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
[TBL] [Abstract][Full Text] [Related]
45. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
46. Antigen-specific transfer of functional programmed death ligand 1 from human APCs onto CD8+ T cells via trogocytosis.
Gary R; Voelkl S; Palmisano R; Ullrich E; Bosch JJ; Mackensen A
J Immunol; 2012 Jan; 188(2):744-52. PubMed ID: 22174448
[TBL] [Abstract][Full Text] [Related]
47. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
VanOosten RL; Griffith TS
Cancer Res; 2007 Dec; 67(24):11980-90. PubMed ID: 18089829
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous analysis of in vivo CD8+ T cell cytotoxicity against multiple epitopes using multicolor flow cytometry.
Fuse S; Usherwood E
Immunol Invest; 2007; 36(5-6):829-45. PubMed ID: 18161531
[TBL] [Abstract][Full Text] [Related]
49. A very rapid and simple assay based on trogocytosis to detect and measure specific T and B cell reactivity by flow cytometry.
Puaux AL; Campanaud J; Salles A; Préville X; Timmerman B; Joly E; Hudrisier D
Eur J Immunol; 2006 Mar; 36(3):779-88. PubMed ID: 16482513
[TBL] [Abstract][Full Text] [Related]
50. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
51. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.
Scholer A; Hugues S; Boissonnas A; Fetler L; Amigorena S
Immunity; 2008 Feb; 28(2):258-70. PubMed ID: 18275834
[TBL] [Abstract][Full Text] [Related]
52. Blockade of LTB(4) /BLT(1) pathway improves CD8(+) T-cell-mediated colitis.
Nancey S; Boschetti G; Hacini F; Sardi F; Durand PY; Le Borgne M; Furhmann L; Flourie B; Kaiserlian D
Inflamm Bowel Dis; 2011 Jan; 17(1):279-88. PubMed ID: 20722054
[TBL] [Abstract][Full Text] [Related]
53. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo.
Luckashenak N; Schroeder S; Endt K; Schmidt D; Mahnke K; Bachmann MF; Marconi P; Deeg CA; Brocker T
Immunity; 2008 Apr; 28(4):521-32. PubMed ID: 18387832
[TBL] [Abstract][Full Text] [Related]
54. Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes.
Baur K; Rauer M; Richter K; Pagenstecher A; Götz J; Hausmann J; Staeheli P
J Virol; 2008 Mar; 82(6):3099-108. PubMed ID: 18184705
[TBL] [Abstract][Full Text] [Related]
55. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
56. A continuous infusion of a minor histocompatibility antigen-immunodominant peptide induces a delay of male skin graft rejection.
Sireci G; Barera A; Macaluso P; Di Sano C; Bonanno CT; Pio La Manna M; Di Liberto D; Dieli F; Salerno A
Immunobiology; 2009; 214(8):703-11. PubMed ID: 19249121
[TBL] [Abstract][Full Text] [Related]
57. Direct stimulation of naïve T cells by antigen-presenting cell vesicles.
Sprent J
Blood Cells Mol Dis; 2005; 35(1):17-20. PubMed ID: 15932799
[TBL] [Abstract][Full Text] [Related]
58. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells.
Hudrisier D; Aucher A; Puaux AL; Bordier C; Joly E
J Immunol; 2007 Mar; 178(6):3637-47. PubMed ID: 17339461
[TBL] [Abstract][Full Text] [Related]
59. Viral interference with antigen presentation.
Yewdell JW; Hill AB
Nat Immunol; 2002 Nov; 3(11):1019-25. PubMed ID: 12407410
[TBL] [Abstract][Full Text] [Related]
60. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity.
Hermans IF; Ritchie DS; Yang J; Roberts JM; Ronchese F
J Immunol; 2000 Mar; 164(6):3095-101. PubMed ID: 10706699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
